You may be entitled to up to $80 million in compensation! Explore Your Legal Rights.
How It Works – Just 3 Simple Steps
100% Confidential. No Risk & No Obligation.
Make Your Voice Heard.
PFAS exposure has been linked to life-altering medical conditions. Filing a lawsuit can help you recover damages for medical costs, lost income, and pain and suffering while sending a powerful message to corporations about their responsibility.
Companies that knowingly contaminated water supplies and products with PFAS must be held accountable. Filing a claim not only secures your future but helps prevent further harm to communities across the nation.
Companies that knowingly contaminated water supplies and products with PFAS must be held accountable. Filing a claim not only secures your future but helps prevent further harm to communities across the nation.
You may qualify to join a Dupixent lawsuit if:
Companies that knowingly contaminated water supplies and products with PFAS must be held accountable. Filing a claim not only secures your future but helps prevent further harm to communities across the nation.
CTCL is a rare type of non-Hodgkin’s lymphoma that begins in the skin’s T-cells. Early symptoms can resemble eczema or psoriasis — redness, itching, and rash — but over time, it can progress to more severe skin lesions and systemic illness.
Because CTCL symptoms often mimic the very conditions Dupixent was designed to treat, diagnosis can be delayed, leading to more advanced disease.
Mycosis fungoides is the most common type of cutaneous T-cell lymphoma, a rare form of non-Hodgkin’s lymphoma that primarily affects the skin. It develops when abnormal T-cells accumulate in the skin, causing red, scaly patches, plaques, or tumors that often resemble eczema or psoriasis. Because of this, diagnosis is often delayed until skin biopsies confirm it.
Sézary Syndrome is a rare and aggressive form of cutaneous T-cell lymphoma, a type of blood cancer that primarily affects the skin. It is characterized by widespread red, itchy, and scaly skin (erythroderma), swollen lymph nodes, and the presence of malignant T-cells called “Sézary cells” in the blood. Unlike other skin lymphomas, Sézary Syndrome involves both the skin and bloodstream, making it more systemic.
Dupixent (dupilumab) is a prescription medication approved to treat eczema, asthma, and chronic sinus conditions. While it has helped many patients manage symptoms, reports and medical findings have linked Dupixent to Cutaneous T-Cell Lymphoma (CTCL) — a rare and potentially life-threatening cancer. Lawsuits claim the manufacturer failed to adequately warn patients and doctors about this serious risk.
CTCL is a rare type of non-Hodgkin’s lymphoma that starts in T-cells, a part of the immune system, and affects the skin. Symptoms can include persistent rashes, redness, itching, and skin lesions. Because these signs can mimic eczema — the very condition Dupixent treats — diagnosis may be delayed, allowing the disease to progress.
Mycosis fungoides is the most common type of cutaneous T-cell lymphoma, a rare form of non-Hodgkin’s lymphoma that primarily affects the skin. It develops when abnormal T-cells accumulate in the skin, causing red, scaly patches, plaques, or tumors that often resemble eczema or psoriasis. Because of this, diagnosis is often delayed until skin biopsies confirm it.
The disease usually progresses slowly over years or decades, and many patients remain in early stages without serious complications. Treatments vary by stage, ranging from skin-directed therapies like corticosteroids, light therapy, or topical chemotherapy, to systemic options such as retinoids, interferon, targeted drugs, or radiation in more advanced cases. While typically not curable once it has spread, mycosis fungoides is often manageable, and patients can live with it for a long time.
Sézary Syndrome is a rare and aggressive form of cutaneous T-cell lymphoma, a type of blood cancer that primarily affects the skin. It is characterized by widespread red, itchy, and scaly skin (erythroderma), swollen lymph nodes, and the presence of malignant T-cells called “Sézary cells” in the blood. Unlike other skin lymphomas, Sézary Syndrome involves both the skin and bloodstream, making it more systemic. Because of its chronic and progressive nature, treatment often requires a combination of therapies to manage symptoms and control the disease.
You may be eligible if:
– You used Dupixent for eczema, asthma, or sinus issues.
– You were diagnosed with Cutaneous T-Cell Lymphoma, Mycosis Fungoides, or Sézary Syndrome during or after use.
– Your diagnosis can be linked to your Dupixent treatment.
The best way to confirm eligibility is to have your case reviewed by an attorney experienced in dangerous drug claims.
Compensation may include:
– Medical bills (past, current, and future treatment costs)
– Lost wages and reduced earning capacity
– Pain and suffering
– Emotional distress
In some cases, punitive damages may be awarded to hold the drug company accountable.
Most dangerous drug attorneys, including our firm, work on a contingency fee basis. This means you pay nothing upfront and no legal fees unless your case is won or settled in your favor.
Every state has a statute of limitations — a strict deadline to file your case. In many states, the clock starts when you are diagnosed with CTCL or discover the possible connection to Dupixent. Acting quickly is critical to protect your rights.
